Abstract
BackgroundTargeting the PD-1/PD-L1/L2 (programmed cell death protein 1/programmed cell death ligand 1/ligand 2) pathway combined with other immunosuppressive signalings, such as CD73/A2aR (A2a adenosine receptor) adenosine signaling, has emerged as...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have